Joaquín Arribas (Joaquin Arribas)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 34

Top Venues

Nature cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

Cancer research

Mar Health Park of Barcelona and Hospital del Mar Institute of Medical Research (PSMAR/IMIM)

Autonomous University of Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Mar Health Park of Barcelona and Hospital del Mar Institute of Medical Research (PSMAR/IMIM)

Spain

Research Director

Vall d'Hebron Insitute of Oncology (VHIO)

Spain

Director :: Preclinical Research Program

Instituciò Catalana de Recerca i Estudis Avancats

Spain

ICREA Research Professor

Autonomous University of Barcelona

Spain

Associate Professor :: Molecular Biology

Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III

Spain

Scientific Director

Hospital Universitari Vall d'Hebron, Servei Català de la Salut

Spain

Coordinator :: Medical Oncology Research Program

Hospital Universitari Vall d'Hebron, Servei Català de la Salut

Spain

Head :: Laboratory of Oncology Research

Memorial Sloan-Kettering Cancer Center

United States

Postdoctoral Researcher :: Supervisor: Joan Massagué

Autonomous University of Madrid

Spain

Predoctoral Fellowship :: Supervisor: José G. Castaño

NCI at Frederick

United States

Predoctoral Fellowship :: Supervisor: Luís Parada

Education History

Autonomous University of Madrid

Spain

PHD

Publications

Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer 5 (3) (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer 5 (3) (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer 5 (3) (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer 5 (3) (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer (2024)
Selim Chaib, José Alberto López-Domínguez, Marta Lalinde-Gutiérrez, Neus Prats, Ines Marin, Olga Boix, Andrea García-Garijo, Kathleen Meyer, María Isabel Muñoz, Mònica Aguilera, Lidia Mateo, Camille Stephan-Otto Attolini, Susana Llanos, Sandra Pérez-Ramos, Marta Escorihuela, Fátima Al-Shahrour, Timothy P Cash, Tamara Tchkonia, James L Kirkland, María Abad, Alena Gros, Joaquín Arribas, Manuel Serrano
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Nature cancer (2024)
Santiago Duro-Sánchez, Macarena Román Alonso, Joaquín Arribas
Immunotherapies against HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Laura Pascual-Reguant, Queralt Serra-Camprubí, Debayan Datta, Damiano Cianferoni, Savvas Kourtis, Antoni Gañez Zapater, Chiara Cannatá, Maria Lorena Espinar Calvo, Jessica Querol, Laura García-López, Sara Musa-Afaneh, Maria Guirola, Anestis Gkanogiannis, Andrea Miró Canturri, Marta Guzman, Olga Rodríguez, Andrea Herencia-Ropero, Joaquín Arribas, Violeta Serra, Luis Serrano, Tian V Tian, Sandra Peiró, Sara Sdelci
Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer. EMBO molecular medicine (2023)
Santiago Duro-Sánchez, Macarena Román Alonso, Joaquín Arribas
Immunotherapies against HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Cristina Saura, Carolina Ortiz, Judit Matito, Enrique J Arenas Lahuerta, Anna Suñol, Ágatha Martín, Octavi Córdoba, Alex Martínez-Sabadell, Itziar Garcia-Ruiz, Ignacio Miranda, Clara Morales-Comas, Estela Carrasco, Cristina Viaplana, Vicente Peg, Paolo G Nuciforo, Neus Bayó-Puxan, Alberto Gonzalez-Medina, Josep M Miquel, Marina Gómez-Rey, Guillermo Villacampa, Silvia A Martínez, Martín Espinosa-Bravo, Judith Balmaña, Rodrigo Dienstmann, Joaquín Arribas, Josep Tabernero, Ana Vivancos, Miriam Sansó
Early-Stage Breast Cancer Detection in Breast Milk. Cancer discovery (2023)
Santiago Duro-Sánchez, Macarena Román Alonso, Joaquín Arribas
Immunotherapies against HER2-Positive Breast Cancer. Cancers 15 (4) (2023)
Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara, Flaminia Pedretti, Alejandro Moles-Fernández, Cristina Viaplana, Guillermo Villacampa, Marta Guzmán, Olga Rodríguez, Judit Grueso, Jose Jiménez, Enrique J Arenas, Andrea Degasperi, Joao M L Dias, Josep V Forment, Lenka Oplustil O'Connor, Olivier Déas, Stefano Cairo, Yinghui Zhou, Antonino Musolino, Carlos Caldas, Serena Nik-Zainal, Robert B Clarke, Paolo G Nuciforo, Orland Díez, Xavier Serres-Créixams, Vicente Peg, Martín Espinosa-Bravo, Teresa Macarulla, Ana Oaknin, Joaquin Mateo, Joaquín Arribas, Rodrigo Dienstmann, Meritxell Bellet-Ezquerra, Mafalda Oliveira, Cristina Saura, Sara Gutiérrez-Enríquez, Judith Balmaña, Violeta Serra
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification. Cancer research 82 (8) (2022)
Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, Urszula M Polanska, Marta Palafox, Andrea Herencia-Ropero, Gemma N Jones, Zhongwu Lai, Joshua Armenia, Filippos Michopoulos, Alba Llop-Guevara, Rachel Brough, Aditi Gulati, Stephen J Pettitt, Krishna C Bulusu, Jenni Nikkilä, Zena Wilson, Adina M Hughes, Paul W G Wijnhoven, Ambar Ahmed, Alejandra Bruna, Albert Gris-Oliver, Marta Guzman, Olga Rodríguez, Judit Grueso, Joaquín Arribas, Javier Cortes, Cristina Saura, Alan Lau, Susan E Critchlow, Brian Dougherty, Carlos Caldas, Gordon B Mills, J Carl Barrett, Josep V Forment, Elaine B Cadogan, Christopher J Lord, Cristina Cruz, Judith Balmaña, Lenka Oplustil O'Connor
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Iván Pérez-Núñez, Catalina Rozalén, José Ángel Palomeque, Irene Sangrador, Mariona Dalmau, Laura Comerma, Anna Hernández-Prat, David Casadevall, Silvia Menendez, Daniel Dan Liu, Minhong Shen, Jordi Berenguer, Irene Rius Ruiz, Raul Peña, José Carlos Montañés, M Mar Albà, Sarah Bonnin, Julia Ponomarenko, Roger R Gomis, Juan Miguel Cejalvo, Sonia Servitja, Diego M Marzese, Lluis Morey, Leonie Voorwerk, Joaquín Arribas, Begoña Bermejo, Marleen Kok, Lajos Pusztai, Yibin Kang, Joan Albanell, Toni Celià-Terrassa
LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer. Nature cancer 3 (3) (2022)
Daniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, Fabio Giuntini, Mariano F Zacarias-Fluck, Laia Foradada, Sandra Martínez-Martín, Erika Serrano, Génesis Martín-Fernández, Sílvia Casacuberta-Serra, Virginia Castillo Cano, Jastrinjan Kaur, Sergio López-Estévez, Miguel Ángel Morcillo Alonso, Mohammad Alzrigat, Loay Mahmoud, Antonio Luque, Marta Escorihuela, Marta Guzman, Joaquín Arribas, Violeta Serra, Lars-Gunnar Larsson, Jonathan R Whitfield, Laura Soucek
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer research communications 2 (2) (2022)
Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez, Enrique J Arenas Lahuerta, Cristina Bernadó Bernadó Morales, Beatriz Morancho, Marta Escorihuela, Sandra Pérez-Ramos, Santiago Escriva-de-Romani, Lucía Gandullo-Sánchez, Atanasio Pandiella, Anna Esteve-Codina, Veronica Rodilla, Fred A Dijcks, Wim H A Dokter, Javier Cortes, Cristina Saura, Joaquín Arribas
Therapy-induced senescence enhances the efficacy of HER2-targeted antibody-drug conjugates in breast cancer. Cancer research (2022)
Chiara Bellio, Marta Emperador, Pol Castellano, Albert Gris-Oliver, Francesc Canals, Alex Sánchez-Pla, Esther Zamora, Joaquín Arribas, Cristina Saura, Violeta Serra, Josep Tabernero, Bruce A Littlefield, Josep Villanueva
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells. Cancers 14 (10) (2022)
Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Nuria Lopez-Bigas, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández-Losa, Faye Su, Kui Lin, Robert B Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C Turner, Aleix Prat, Paolo G Nuciforo, Rodrigo Dienstmann, Chandra S Verma, Núria López-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer. Nature communications 13 (1) (2022)
Marta Palafox, Laia Monserrat, Meritxell Bellet, Guillermo Villacampa, Nuria Lopez-Bigas, Mafalda Oliveira, Fara Brasó-Maristany, Nusaibah Ibrahimi, Srinivasaraghavan Kannan, Leonardo Mina, Maria Teresa Herrera-Abreu, Andreu Òdena, Mònica Sánchez-Guixé, Marta Capelán, Analía Azaro, Alejandra Bruna, Olga Rodríguez, Marta Guzmán, Judit Grueso, Cristina Viaplana, Javier Hernández-Losa, Faye Su, Kui Lin, Robert B Clarke, Carlos Caldas, Joaquín Arribas, Stefan Michiels, Alicia García-Sanz, Nicholas C Turner, Aleix Prat, Paolo G Nuciforo, Rodrigo Dienstmann, Chandra S Verma, Núria López-Bigas, Maurizio Scaltriti, Monica Arnedos, Cristina Saura, Violeta Serra
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER + breast cancer. Nature communications 13 (1) (2022)
Daniel Massó-Vallés, Marie-Eve Beaulieu, Toni Jauset, Fabio Giuntini, Mariano F Zacarias-Fluck, Laia Foradada, Sandra Martínez-Martín, Erika Serrano, Génesis Martín-Fernández, Sílvia Casacuberta-Serra, Virginia Castillo Cano, Jastrinjan Kaur, Sergio López-Estévez, Miguel Ángel Morcillo Alonso, Mohammad Alzrigat, Loay Mahmoud, Antonio Luque, Marta Escorihuela, Marta Guzman, Joaquín Arribas, Violeta Serra, Lars-Gunnar Larsson, Jonathan R Whitfield, Laura Soucek
MYC Inhibition Halts Metastatic Breast Cancer Progression by Blocking Growth, Invasion, and Seeding. Cancer research communications 2 (2) (2022)
Queralt Serra-Camprubí, Helena Verdaguer, Winona Oliveros, Núria Lupión-Garcia, Alba Llop-Guevara, Cristina Molina, Maria Vila-Casadesús, Anthony Turpin, Cindy Neuzillet, Joan Frigola, Jessica Querol, Mariana Yáñez-Bartolomé, Florian Castet, Carles Fabregat-Franco, Carmen Escudero-Iriarte, Marta Escorihuela, Enrique J Arenas Lahuerta, Cristina Bernadó Bernadó Morales, Noemí Haro, Francis J Giles, Oscar J Pozo, Josep M Miquel, Paolo G Nuciforo, Ana Vivancos, Marta Melé, Violeta Serra, Joaquín Arribas, Josep Tabernero, Sandra Peiró, Teresa Macarulla, Tian V Tian
Human metastatic cholangiocarcinoma patient-derived xenografts and tumoroids for preclinical drug evaluation. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Faiz Bilal, Enrique J Arenas, Kim Pedersen, Alex Martínez-Sabadell, Behnam Nabet, Elisabeth Guruceaga, Silvestre Vincent, Josep Tabernero, Teresa Macarulla, Joaquín Arribas
The Transcription Factor SLUG Uncouples Pancreatic Cancer Progression from the RAF-MEK1/2-ERK1/2 Pathway. Cancer research 81 (14) (2021)
Enrique J Arenas Lahuerta, Alex Martínez-Sabadell, Irene Rius Ruiz, Macarena Román Alonso, Marta Escorihuela, Antonio Luque, Carlos Alberto Fajardo, Alena Gros, Christiane Neumann, Joaquín Arribas
Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. Nature communications 12 (1) (2021)
Alex Martínez-Sabadell, Enrique J Arenas, Joaquín Arribas
IFNγ Signaling in Natural and Therapy-Induced Antitumor Responses. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Alison E Smith, Emanuela Ferraro, Anton Safonov, Cristina Bernado Morales, Enrique J Arenas Lahuerta, Qing Li, Amanda Kulick, Dara Ross, David B Solit, Elisa de Stanchina, Jorge Sergio Reis-Filho, Neal X Rosen, Joaquín Arribas, Pedram Razavi, Sarat Chandarlapaty
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway. Nature communications 12 (1) (2021)
Alfonso García-Valverde, Jordi Rosell, Sergi Sayols, David Gómez-Peregrina, Daniel F Pilco-Janeta, Iván Olivares-Rivas, Enrique de Álava, Joan Maurel, Jordi Rubió-Casadevall, Anna Esteve, Marta Gut, Claudia Valverde, Jordi Barretina, Joan Carles, George D Demetri, Jonathan A Fletcher, Joaquín Arribas, Cesar Serrano
E3 ubiquitin ligase Atrogin-1 mediates adaptive resistance to KIT-targeted inhibition in gastrointestinal stromal tumor. Oncogene 40 (48) (2021)
Albert Gris-Oliver, Marta Palafox, Laia Monserrat, Fara Brasó-Maristany, Andreu Òdena, Mònica Sánchez-Guixé, Yasir H Ibrahim, Guillermo Villacampa, Judit Grueso, Mireia Parés, Marta Guzmán, Olga Rodríguez, Alejandra Bruna, Caroline S Hirst, Alan Barnicle, Elza C de Bruin, Avinash Reddy, Gaia Schiavon, Joaquín Arribas, Gordon B Mills, Carlos Caldas, Rodrigo Dienstmann, Aleix Prat, Paolo G Nuciforo, Pedram Razavi, Maurizio Scaltriti, Nicholas C Turner, Cristina Saura, Barry R Davies, Mafalda Oliveira, Violeta Serra
Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Alfonso García-Valverde, Jordi Rosell, Garazi Serna, Claudia Valverde, Joan Carles, Paolo G Nuciforo, Jonathan A Fletcher, Joaquín Arribas, Oliver Politz, César Serrano
Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor. Molecular cancer therapeutics 19 (6) (2020)
Jorge Gómez-Miragaya, Ander Díaz-Navarro, Raul Tonda, Sergi Beltran, Luis Palomero, Marta Palafox, Lacey E Dobrolecki, Chen Huang, Suhas Vasaikar, Bing Zhang, Gerburg M Wulf, Alejandro Collado-Sole, Eva María Trinidad, Purificación Muñoz, Laia Paré, Aleix Prat, Alejandra Bruna, Carlos Caldas, Joaquín Arribas, María Teresa Soler-Monso, Anna Petit, Judith Balmaña, Cristina Cruz, Violeta Serra, Miguel Angel Pujana, Michael T Lewis, Xose S Puente, Eva González-Suárez
Chromosome 12p Amplification in Triple-Negative/BRCA1-Mutated Breast Cancer Associates with Emergence of Docetaxel Resistance and Carboplatin Sensitivity. Cancer research 79 (16) (2019)
Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan, Corrado Carrisi, Daniela Bellarosa, Massimiliano Salerno, Rossana Bugianesi, Rosanna Manno, Cristina Bernadó Morales, Joaquín Arribas, Rachel L Dusek, James E Ackroyd, Phuoc Huy Pham, Rahel Awdew, Dee Aud, Michael Trang, Carmel M Lynch, Jonathan Terrett, Keith E Wilson, Christian Rohlff, Stefano Manzini, Andrea Pellacani, Monica Binaschi
MEN1309/OBT076, a First-In-Class Antibody-Drug Conjugate Targeting CD205 in Solid Tumors. Molecular cancer therapeutics 18 (9) (2019)
Irene Rius Ruiz, Rocio Vicario, Beatriz Morancho, Cristina Bernadó Morales, Enrique J Arenas Lahuerta, Sylvia Herter, Anne Freimoser-Grundschober, Jitka Somandin, Johannes Sam, Oliver Ast, Águeda Martinez Barriocanal, Antonio Luque, Marta Escorihuela, Ismael Varela, Isabel Cuartas, Paolo G Nuciforo, Roberta Fasani, Vicente Peg, Isabel Rubio, Javier Cortes, Violeta Serra, Santiago Escriva-de-Romani, Jeff Sperinde, Ahmed Chenna, Weidong Huang, John Winslow, Joan Albanell, Joan Seoane, Maurizio Scaltriti, Jose Baselga, Josep Tabernero, Pablo Umana, Marina Bacac, Cristina Saura, Christiane Neumann, Joaquín Arribas
p95HER2-T cell bispecific antibody for breast cancer treatment. Science translational medicine 10 (461) (2019)
Shin-Ae Kang, Jye Swei Guan, Hock Jin Tan, Tinghine Chu, Aye Aye Thike, Cristina Bernadó, Joaquín Arribas, Chow Yin Wong, Puay Hoon Tan, Mihir Gudi, Thomas Choudary Putti, Joohyuk Sohn, Swee Ho Lim, Soo Chin Lee, Yoon Pin Lim
Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (8) (2018)

Joaquín Arribas.css-eqlu8i{font-size:small;padding-left:4px;} (Joaquin Arribas)

Publication Activity (10 Years)

Top Topics

Top Venues

Joaquín Arribas (Joaquin Arribas)